About Design Therapeutics, Inc. 
Design Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 32 Schemes (11.34%)
Foreign Institutions
Held by 40 Foreign Institutions (1.76%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-19 Million
Pharmaceuticals & Biotechnology
USD 331 Million ()
NA (Loss Making)
NA
0.00%
-1.01
-29.80%
1.56






